The board of directors at CAMP4 Therapeutics comprises experienced biotechnology executives, financial experts, and independent industry leaders guiding its clinical development strategy. Recent corporate governance updates include the appointment of veteran life sciences executive Michael MacLean to the board, adding extensive financial leadership and public biopharmaceutical expertise alongside other specialized directors who oversee the company's scientific advancement, operational growth, and regulatory compliance frameworks.